Biochemical markers in the management of pulmonary hypertension

John-David Aubert

doi:10.4414/smw.2005.10723

DOI:: https://doi.org/10.4414/smw.2005.10723

Fulltext PDF

Cite this as:: Swiss Med Wkly. 2005;135:43-43
Published: 29.01.2005

How to Cite

1.

Biochemical markers in the management of pulmonary hypertension. Swiss Med Wkly [Internet]. 2005 Jan. 29 [cited 2026 Apr. 1];135(0304):43-. Available from: https://smw.ch/index.php/smw/article/view/455

Share

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

PubMed

Donate

Please consider making a donation to support this journal and our commitment to the Diamond Open Access model.

Most read articles by the same author(s)

Benoit Lechartier, Ari Chaouat, John-David Aubert, Juerg Schwitter, Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives , Swiss Medical Weekly: Vol. 152 No. 0506 (2022)
Patrick Yerly, Maura Prella, John-David Aubert, Current management of pulmonary arterial hypertension , Swiss Medical Weekly: Vol. 146 No. 2122 (2016)
Christian Benden, Sarah R. Haile, Nathalie Kruegel, Franziska Beyeler, John-David Aubert, Isabelle Binet, Déla Golshayan, Karine Hadaya, Thomas F. Mueller, Paloma Parvex, Franz F. Immer, SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list , Swiss Medical Weekly: Vol. 150 No. 5153 (2020)
Andreas Elmer, Matthias Birrer, Julius Weiss, John-David Aubert, Christian Benden, Ilhan Inci, Thorsten Krueger, Paola M. Soccal, Franz F. Immer, Extended-criteria donors in lung transplantation in Switzerland: an evaluation of two adapted lung donor scores , Swiss Medical Weekly: Vol. 148 No. 1718 (2018)